Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.

Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer. Cancer Cell. 2015 Jul 13; 28(1):7-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.